AVXL
Anavex Life Sciences Corp
NASDAQ: AVXL · HEALTHCARE · BIOTECHNOLOGY
$3.34
+2.45% today
Updated 2026-04-30
Market cap
$309.52M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.46
Dividend yield
—
52W range
$3 – $14
Volume
1.4M
Anavex Life Sciences Corp (AVXL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-33.60%
ROA
-21.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-25532.00 | — | — | — |
| 2007 | — | $-1.58M | — | — | — |
| 2008 | — | $-5.35M | — | — | — |
| 2009 | — | $-5.50M | — | — | — |
| 2010 | — | $-8.78M | — | — | — |
| 2011 | — | $-7.31M | — | — | — |
| 2012 | — | $-8.30M | — | — | — |
| 2013 | $0.00 | $-3.70M | — | — | — |
| 2014 | $0.00 | $-11.37M | — | — | — |
| 2015 | $0.00 | $-12.11M | — | — | — |
| 2016 | $0.00 | $-14.74M | — | — | — |
| 2017 | $0.00 | $-13.46M | — | — | — |
| 2018 | $0.00 | $-17.45M | — | — | — |
| 2019 | $-685000.00 | $-26.29M | — | 4,197.37% | 3,838.68% |
| 2020 | $0.00 | $-26.28M | — | — | — |
| 2021 | $0.00 | $-37.91M | — | — | — |
| 2022 | $0.00 | $-47.98M | — | — | — |
| 2023 | $0.00 | $-47.49M | — | — | — |
| 2024 | $0.00 | $-43.00M | — | — | — |
| 2025 | $0.00 | $-46.38M | — | — | — |